Results for tag: "REM Sleep Behavior Disorder Drug"

REM Sleep Behavior Disorder (RBD) is a neurological disorder characterized by abnormal behavior during REM sleep. It is associated with a variety of neurological conditions, including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. Treatment of RBD typically involves the use of central nervous system (CNS) drugs, such as clonazepam, melatonin, and pramipexole. These drugs are used to reduce the frequency and intensity of the abnormal behaviors associated with RBD. The REM Sleep Behavior Disorder Drug market is a subset of the larger CNS drug market. It is composed of a variety of drugs used to treat RBD, as well as other neurological conditions. The market is highly competitive, with a number of companies offering products for the treatment of RBD. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more